يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"MESH: Drugs, Generic"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul – Turkey

    المؤلفون: Toklu, Hale Z., Dülger, Gül A., Hıdıroğlu, Seyhan, Akici, Ahmet, Yetim, Aslıhan, Gannemoğlu, H. Mustafa, Güneş, Haşim

    المصدر: Pharmacy Practice

    مصطلحات موضوعية: mesh:Pharmacists, mesh:Drugs, Generic, mesh:Health Knowledge, Attitudes, Practice, mesh:Physicians, mesh:Turkey, health care economics and organizations, humanities, Original Research

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::08273cff01a81dd655bdadc1aff441b0
    http://europepmc.org/articles/PMC3780497

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  2. 2
    Acceptation des médicaments génériques en fonction des classes thérapeutiques

    المؤلفون: Lacrampe, Mathilde

    المساهمون: Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), Jean-François Bergmann

    المصدر: Médecine humaine et pathologie. 2016

    مصطلحات موضوعية: MESH: Aged, Médicaments génériques, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Patient Acceptance of Health Care, Acceptation des soins par les patients, MESH: Drugs, Generic, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Sujets âgés

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2fa3c4e27fe71d4ca9abd829c86940d7
    https://dumas.ccsd.cnrs.fr/dumas-01310504/document

    أضف إلى المفضلة
  3. 3
    How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?

    المؤلفون: Pieter Dylst, Steven Simoens, Arnold G. Vulto

    المصدر: Pharmacy Practice (Granada) v.10 n.1 2012
    SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
    instname
    Pharmacy Practice

    مصطلحات موضوعية: mesh:Drug Substitution, Medical education, medicine.medical_specialty, Traditional medicine, Drug Substitution, business.industry, Fees, Pharmacist, Alternative medicine, Drugs, Review, Pharmacists, Generic, mesh:Europe, Europe, Incentive, Pharmaceutical care, Pharmaceutical, Health care, Remuneration, medicine, mesh:Fees, Pharmaceutical, mesh:Pharmacists, mesh:Drugs, Generic, business

    وصف الملف: text/html

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb885c694c44d63df589462df0475247
    https://doi.org/10.4321/s1886-36552012000100002

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  4. 4
    [About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)]

    المؤلفون: Philippe, Nicot, Irène, Frachon, Catherine, Hill

    المساهمون: Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Institut Gustave Roussy (IGR)

    المصدر: La Presse medicale
    La Presse medicale, Paris, Masson et Cie, 2013, 42 (4 Pt 1), pp.411-8. ⟨10.1016/j.lpm.2013.02.310⟩

    مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, MESH: Expert Testimony, Drug Industry, MESH: Probability, [SDV]Life Sciences [q-bio], Aortic Valve Insufficiency, Eligibility Determination, MESH: Causality, MESH: Fenfluramine, Diagnosis, Differential, MESH: Cross-Sectional Studies, MESH: Eligibility Determination, Risk Factors, MESH: Appetite Depressants, MESH: Risk Factors, MESH: Diagnosis, Differential, Appetite Depressants, Fenfluramine, Drugs, Generic, Humans, Expert Testimony, MESH: Drugs, Generic, Probability, MESH: Humans, MESH: Compensation and Redress, Mitral Valve Insufficiency, MESH: Aortic Valve Insufficiency, Causality, MESH: France, Cross-Sectional Studies, MESH: Drug Industry, Compensation and Redress, France

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ebc8a6a7a6ef4ef74b6a4ab69d4be3dd
    https://hal.univ-brest.fr/hal-00935392

    أضف إلى المفضلة
  5. 5
    Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting

    المؤلفون: Véronique Lamarque, Louis Merle, Jean Paul Demarez, Haleh Bagheri, Arnaud Biraben, Jean-Paul Fagot, Jean-Dominique Hamel, Carmen Kreft-Jaïs, Françoise Haramburu, Marie-Laure Laroche, Hervé Le Louet, Claire Martray, Jacques Mascaro, Christian Pisano, Myriam Rosilio, Franck Rouby, Alain Saint-Pierre, Éric Singlas

    المساهمون: Equipe de Recherche Médicale Appliquée (ERMA), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Université de Limoges (UNILIM)-CHU Limoges

    المصدر: Thérapie
    Thérapie, EDP Sciences, 2008, 63 (4), pp.301-9. ⟨10.2515/therapie:2008047⟩

    مصطلحات موضوعية: Quality Control, Traceability, MESH: Quality Control, Pharmacology, Interchangeability, MESH: Therapeutic Equivalency, 03 medical and health sciences, 0302 clinical medicine, SAFER, Generic drug, Pharmacovigilance, Health care, Product Surveillance, Postmarketing, Medicine, Drugs, Generic, Humans, Pharmacology (medical), MESH: Product Surveillance, Postmarketing, MESH: Drugs, Generic, 030304 developmental biology, 0303 health sciences, Modalities, MESH: Humans, business.industry, Research, MESH: Legislation, Drug, Biosimilar, Legislation, Drug, 3. Good health, MESH: France, MESH: Research, Risk analysis (engineering), Therapeutic Equivalency, France, business, 030217 neurology & neurosurgery, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e35678bc10d94b1dac8b10c545cd0a
    https://pubmed.ncbi.nlm.nih.gov/18937910

    View record from ScienceDirect
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء